Clinical applications of corneal cells derived from induced pluripotent stem cells

Source
Biomolecules - ISSN 2218-273X-15:8 (2025) p. 1-20
Author(s)

Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer

Source
Clinical cancer research - ISSN 1078-0432-29:3 (2023) p. 635-646

Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients

Source
Cancers - ISSN 2072-6694-13:22 (2021) p. 1-19
Author(s)

Heparin-based, injectable microcarriers for controlled delivery of interleukin-13 to the brain

Source
Biomaterials Science - ISSN 2047-4830-8:18 (2020) p. 4997-5004
Author(s)
    Lucas Schirmer, Chloé Hoornaert, Debbie Le Blon, Dimitri Eigel, Catia Neto, Mark Gumbleton, Petra B. Welzel, Anne E. Rosser, Carsten Werner, Peter Ponsaerts, Ben Newland

Murine induced pluripotent stem cell-derived neuroimmune cell culture models emphasize opposite immune-effector functions of interleukin 13-primed microglia and macrophages in terms of neuroimmune toxicity

Source
Glia - ISSN 0894-1491- () p. 1-20
Author(s)